Series details
Sub-series Health Technology Assessment (HTA)
Series:
ISSN:
No ISSN
|
Available item(s) in this sub-series (138)


64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease / Hans Van Brabandt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2008)
![]()
64-Slice computed tomography imaging of coronary arteries in patients suspected for coronary artery disease [printed text] / Hans Van Brabandt, Author ; Cécile Camberlin
, Author ; Irina Cleemput
. - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2008 . - vii, 100 p. : ill. ; 30 cm.. - (KCE Reports. Health Technology Assessment (HTA); 82C) .
ISSN : D/2008/10.273/42
Study nr : 2007-06
Languages : English (eng)
Descriptors: Indexation
2007-06 ; Belgium ; Coronary Disease ; R82 ; Technology Assessment, Biomedical ; Tomography, X-Ray Computed
Classification
WG 141 -- Examination. Diagnosis. Diagnostic methods (General and heart specifically)Class number: 005.54 Link for e-copy: https://doi.org/10.57598/R82C Format of e-copy: .PDF (813 KB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=1242 Copies
Barcode Call number Media type Location Section Status No copy Anticoagulants in non-valvular atrial fibrillation / Hans Van Brabandt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
![]()
Anticoagulants in non-valvular atrial fibrillation [printed text] / Hans Van Brabandt, Author ; Lorena San Miguel
, Author ; Nicolas Fairon
, Author ; Bert Vaes, Author ; Séverine Henrard, Author ; Anelia Boshnakova, Author ; Rob Cook, Author ; Rob Davies, Author ; Aditi Karnad, Author ; Alan Lovell, Author ; Cécile Dubois
, Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2016 . - 195 p. : ill., ; A4. - (KCE Reports. Health Technology Assessment (HTA); 279) .
ISSN : D/2016/10.273/101 : 0,00
Study 2015-05
Languages : English (eng)
Descriptors: Indexation
2015-05 ; Anticoagulants ; Atrial Fibrillation ; Belgium ; Cost-Benefit Analysis ; Physician's Practice Patterns ; Practice Guidelines as Topic ; R279 ; Secondary Prevention
Classification
QV 193 AnticoagulantsContents note: LIST OF FIGURES 6 -- LIST OF TABLES 8 -- LIST OF ABBREVIATIONS 10 -- SCIENTIFIC REPORT 12 -- 1 AIMS 12 -- 2 INTRODUCTION 13 -- 3 BACKGROUND 13 -- 3 1 ANTITHROMBOTICS13 -- 3 3 STROKE RISK ASSESSMENT IN ATRIAL FIBRILLATION 14 -- 3 4 STROKE PREVENTION IN ATRIAL FIBRILLATION 19 -- 3 4 1 Vitamin K antagonists 19 -- 3 4 2 Antiplatelets 19 -- 3 4 3 Combination therapy of anticoagulants and antiplatelets 20 -- 3 4 4 Novel Oral AntiCoagulants (NOACs) 20 -- 3 5 BLEEDING RISK INDUCED BY VITAMIN K ANTAGONISTS 21 -- 4 EFFICACY AND SAFETY OF NOACS 23 -- 4 1 SEARCH STRATEGY 23 -- 4 2 SYSTEMATIC REVIEWS 25 -- 4 3 PRIMARY STUDIES 26 -- 4 3 1 Ximelagatran 26 -- 4 3 2 Dabigatran 26 -- 4 3 3 Rivaroxaban 27 -- 4 3 4 Apixaban 28 -- 4 3 5 Edoxaban 28 -- 4 3 6 Summary table 28 -- 4 4 SAFETY OF NOACS 30 -- 4 5 RISK OF BIAS IN PIVOTAL RCTS 31 -- 4 6 INTERNATIONAL PRACTICE GUIDELINES 32 -- 5 REIMBURSEMENT OF ANTICOAGULANTS IN BELGIUM 35 -- 6 ADHERENCE TO ANTICOAGULATION GUIDELINES IN PRACTICE 37 -- 6 1 PHYSICIANS ADHERENCE TO GUIDELINES 37 -- 6 1 1 Literature search 37 -- 6 1 2 Systematic reviews 38 -- 6 1 3 AF patient registries 38 -- 6 2 PHYSICIANS ADHERENCE TO APPROPRIATE DOSE PRESCRIPTION 42 -- 6 2 1 VKA dosing 42 -- 6 2 2 NOAC dosing 42 -- 6 3 PATIENTS ADHERENCE TO ANTICOAGULANT PRESCRIPTION 43 -- 7 CLINICAL USE OF ANTICOAGULANTS IN NON-VALVULAR AF: DISCUSSION 45 -- 7 1 STROKE RISK ASSOCIATED WITH AF, VERSUS BLEEDING RISK ASSOCIATED WITH ANTICOAGULANTS 45 -- 7 1 1 Undertreatment in high risk populations with a CHA2DS2-VASc risk score of ≥2 (♂) or ≥3 (♀) 47 -- 7 1 2 Overtreatment in low risk populations with a CHA2DS2-VASc risk score of 0 (or 1 in ♀ with no additional risk factors)47 -- 7 1 3 Anticoagulation in patients with a CHA2DS2-VASc risk score of 1 (♂) or 2 (♀) 47 -- 7 1 4 Patients adherence to anticoagulants 47 -- 7 2 NEW ORAL ANTICOAGULANTS VS VITAMIN K ANTAGONISTS 48 -- 7 2 1 Effect of NOACs versus VKAs on stroke 48 -- 7 2 2 Effect of NOACs versus VKAs on bleeding 48 -- 7 2 3 Drug monitoring and compliance to treatment 49 -- 8 COST-EFFECTIVENESS OF NOACS 50 -- 8 1 INTRODUCTION 50 -- 8 2 METHODS 50 -- 8 2 1 Literature review 50 -- 8 2 2 Selection process 50 -- 8 3 RESULTS 53 -- 8 3 1 Overview of economic evaluations 53 -- 8 3 2 Type of economic evaluation 57 -- 8 3 3 Time frame and discounting 58 -- 8 3 4 Perspective 58 -- 8 3 5 Population 58 -- 8 3 6 Intervention and comparator 59 -- 8 3 7 Cost and outcome inputs 59 -- 8 3 8 Industry sponsorship 59 -- 8 3 9 Costs 60 -- 8 3 10 Incremental Cost-effectiveness Ratios (ICERs) 78 -- 8 3 11 Sensitivity Analyses 84 -- 8 3 12 Subgroup Analyses 84 -- 8 3 13 Studies in Belgium 85 -- 8 3 14 NICE Health Technology Assessments 91 -- 8 4 DISCUSSION AND CONCLUSIONS 91 -- 8 4 1 Use of adapted models 91 -- 8 4 2 Assumptions and sources of data 92 -- 8 4 3 Conflict of interests 92 -- 8 4 4 Relevance to Belgian healthcare system 92 -- 8 4 5 Conclusions 92 -- 9 FLEMISH GENERAL PRACTITIONERS DATA 94 -- 9 1 INTRODUCTION 94 -- 9 2 METHODOLOGY 95 -- 9 2 1 Description of the Intego database 95 -- 9 2 2 Clinical research questions 95 -- 9 2 3 Patient selection 95 -- 9 2 4 Definition of clinical variables and medications 97 -- 9 2 5 Statistical analysis 100 -- 9 3 RESULTS 101 -- 9 3 1 Prescription of oral anticoagulants in general practice in the general population and validation of proxies for the CHA2DS2-VASc and CHADS2 scores (part 1) 101 -- 9 3 2 Trends in prescriptions of OACs in general practice in people with atrial fibrillation (part 2) 107 -- 9 4 CONCLUSIONS 125 -- 9 4 1 Prescription of oral anticoagulants in general practice in the general population and validation of proxies for the CHA2DS2-VASc and CHADS2 scores (part 1) 125 -- 9 4 2 Trends in prescriptions of oral anticoagulants in general practice in people with atrial fibrillation (part 2) 125 -- 10 ANALYSIS OF BELGIAN DATA 126 -- 10 1 INTRODUCTION 126 -- 10 2 METHODS 126 -- 10 2 1 General Methodology 126 -- 10 3 DATA LIMITATIONS 128 -- 10 4 RESULTS 128 -- 10 4 1 Evolution over time 128 -- 10 4 2 Profile of the anticoagulant users 132 -- 10 5 DISCUSSION 145 -- 11 FINAL CONCLUSION147 -- 11 1 TO ANTICOAGULATE OR NOT? 147 -- 11 1 1 Risk of stroke risk associated with non-valvular AF 147 -- 11 1 2 Net clinical benefit of anticoagulants 147 -- 11 1 3 Overdiagnosis and oveartreatment 148 -- 11 1 4 Undertreatment 148 -- 11 2 VKA OR NOAC? 149 -- 11 2 1 Advantages of NOACs versus VKAs 149 -- 11 2 2 Disadvantages of NOACs versus VKAs 149 -- 11 2 3 VKA or NOAC: KCEs conclusion 150 -- 11 3 TRENDS IN ANTICOAGULANT PRESCRIPTION 151 -- APPENDICES 152 -- APPENDIX 1 RCTS COMPARING NOACS WITH VKA IN NON-VALVULAR AF 152 -- APPENDIX 2 LITERATURE SEARCH FOR EFFICACY OF NOAC 153 -- APPENDIX 3 SUMMARY OF FINDINGS TABLES 157 -- APPENDIX 4 META-ANALYSES OF ISCHEMIC STROKE RISK BY CHA2DS2-VASC SCORE 164 -- APPENDIX 5 SYSTEMATIC REVIEWS ON INAPPROPRIATE USE OF ORAL ANTICOAGULANTS 166 -- APPENDIX 6 SEARCH STRATEGIES FOR C-E CHAPTER 172 -- APPENDIX 7 APPENDICES TO FLEMISH GPS DATA 174 -- APPENDIX 8 APPENDICES TO BELGIAN IMA DATA 184 -- REFERENCES 186 Link for e-copy: https://doi.org/10.57598/R279C Format of e-copy: PDF (4,8 MB) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3966 Anticoagulants in non-valvular atrial fibrillation / Hans Van Brabandt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2016)
![]()
Anticoagulants in non-valvular atrial fibrillation : Synthesis [printed text] / Hans Van Brabandt, Author ; Lorena San Miguel
, Author ; Nicolas Fairon
, Author ; Bert Vaes, Author ; Séverine Henrard, Author ; Anelia Boshnakova, Author ; Rob Cook, Author ; Rob Davies, Author ; Aditi Karnad, Author ; Alan Lovell, Author ; Cécile Dubois
, Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2016 . - 22 p. : ill., ; A4. - (KCE Reports. Health Technology Assessment (HTA); 279Cs) .
ISSN : D/2016/10.273/100 : 0,00
Study 2015-05
Languages : English (eng)
Descriptors: Indexation
2015-05 ; Anticoagulants ; Atrial Fibrillation ; Belgium ; Cost-Benefit Analysis ; Physician's Practice Patterns ; Practice Guidelines as Topic ; R279 ; Secondary Prevention
Classification
QV 193 AnticoagulantsContents note: FOREWORD -- KEY MESSAGES 2 -- SYNTHESE 4 -- 1. OBJECTIVES OF THIS STUDY 6 -- 2. ATRIAL FIBRILLATION 6 -- 2.1. A SILENT DISORDER WITH POTENTIALLY SERIOUS CONSEQUENCES 6 -- 2.2. ASSESSMENT OF THE THROMBOEMBOLIC RISK 7 -- 3. EFFICACY OF ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION 8 -- 3.1. VITAMIN K ANTAGONISTS 8 -- 3.2. NOVEL ORAL ANTICOAGULANTS (NOACS) 8 -- 3.3. COMPARISON OF THE EFFICACY OF VKAS AND NOACS 9 -- 4. PRACTICAL: PRESCRIBE ANTICOAGULANTS OR NOT? 11 -- 4.1. FINDING THE BALANCE BETWEEN THE RISK OF ISCHEMIC AND HAEMORRHAGIC STROKE.11 -- 4.2. OVERTREATMENT 12 -- 4.3. UNDERTREATMENT 12 -- 4.4. SPECIAL CASE: PATIENTS WITH A CHA2DS2-VASC SCORE = 1 (FOR MEN) AND = 2 (FOR WOMEN) 13 -- 4.5. ADDITIONAL OBSERVATIONS 14 -- 5. MONITORING A PATIENT ON ANTICOAGULANTS 15 -- 5.1. MONITORING COAGULATION 15 -- 5.2. MONITORING COMPLIANCE 15 -- 5.3. A NEW FORM OF UNDERTREATMENT WITH NOACS 16 -- 5.4. REVERSIBILITY OF THE ANTICOAGULANT EFFECT AND ANTIDOTES 16 -- 6. ECONOMIC ASPECTS 17 -- 6.1. REIMBURSEMENT OF NOACS IN BELGIUM 17 -- 6.2. ECONOMIC EVALUATIONS 18 -- 7. CONCLUSIONS 19 -- 7.1. ANTICOAGULANTS OR NOT? 19 -- 7.2. VKA OR NOAC 19 -- 7.2.1. Advantages of NOACs compared to VKAs 19 -- 7.2.2. Disadvantages of NOACs compared to VKAs 19 -- 7.2.3. Conclusion 20 Link for e-copy: https://doi.org/10.57598/R279CS Format of e-copy: PDF (847 Kb) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3967 Autologous breast reconstruction techniques after mammary resection / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
![]()
Autologous breast reconstruction techniques after mammary resection : time measurements for a potential reevaluation of the surgeon fee [printed text] / Sophie Gerkens, Author ; Stefaan Van de Sande
, Author ; Roos Leroy
, Author ; Anne-Sophie Mertens, Author ; Jonathan Schreiber, Author ; Dries Van Halewyck, Author ; Jan Bellaert, Author ; Hans Van Brabandt
, Author ; Nathalie Swartenbroekx, Author ; Caroline Obyn, Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2015 . - 102 p. : ill., ; A4. - (KCE Reports. Health Technology Assessment (HTA); 251) .
ISSN : D/2015/10/273/77 : 0,00
Study 2014-25_HTA_Cost_breast_reconstruction
Languages : English (eng)
Descriptors: Classification
W 74 Medical economics. Health care costs (General)
Indexation
2014-25 ; Costs and Cost Analysis ; Documents related to KCE studies ; Hospital Costs ; Mammaplasty ; Operative Time ; R251 ; Reimbursement Mechanisms ; Surgical FlapsContents note: SCIENTIFIC REPORT .9 -- 1 INTRODUCTION 9 -- 1.1 BACKGROUND AND OBJECTIVES 9 -- 1.2 RESEARCH QUESTIONS 9 -- 1.3 DESCRIPTION OF AUTOLOGOUS BREAST RECONSTRUCTION INTERVENTIONS .10 -- 1.3.1 The primary reconstruction or the flap transfer .10 -- 1.3.2 Secondary interventions 14 -- 2 THE CLINICAL EFFECTIVENESS AND SAFETY OF AUTOLOGOUS BREAST RECONSTRUCTION .15 -- 2.1 INTRODUCTION .15 -- 2.2 METHODS 15 -- 2.2.1 Literature search 15 -- 2.2.2 Quality appraisal and data extraction .16 -- 2.3 RESULTS 16 -- 2.4 GENERAL CONCLUSIONS 24 -- 3 BELGIAN PRACTICE: ANALYSES OF BELGIAN HOSPITAL ADMINISTRATIVE DATA 25 -- 3.1 INTRODUCTION .25 -- 3.1.1 Main characteristics of the data sources 25 -- 3.1.2 Cross-sectional data window .26 -- 3.2 METHODS 26 -- 3.2.1 Research questions 26 -- 3.2.2 Target interventions 27 -- 3.2.3 Selection criteria for data extractions .27 -- 3.2.4 Data extraction, transformation and loading (ETL) .27 -- 3.2.5 Checking exhaustiveness of data extraction 29 -- 3.2.6 Check marking codes and stays for breast cancer .29 -- 3.2.7 Research focus tables 29 -- 3.2.8 Grouping interventions and complications 30 -- 3.2.9 Investigating complications in administrative hospital data 31 -- 3.2.10 investigating intervention lead times 32 -- 3.2.11 Calculating fractions and ratios .32 -- 3.2.12 Health insurance costs calculations 33 -- 3.3 RESULTS 34 -- 3.3.1 General results for index interventions .34 -- 3.3.2 Complication rates 40 -- 3.3.3 Intervention lead times 44 -- 3.3.4 Fractions & ratios .45 -- 3.3.5 Health insurance costs 47 -- 3.4 LIMITATIONS AND MAIN FIGURES 51 -- 4 TIME MEASUREMENTS AND VALUATION SCENARIOS FOR THE SURGEON COST .53 -- 4.1 INTRODUCTION .53 -- 4.2 SCOPE OF THE STUDY.53 -- 4.2.1 Perspective .53 -- 4.2.2 Treatment considered: the full autologous breast reconstruction episode with flap 53 -- 4.3 TIME DRIVEN COSTING METHODOLOGY 54 -- 4.4 RECRUITMENT AND SELECTION OF THE SURGEON TEAMS 54 -- 4.4.1 Recruitment .54 -- 4.4.2 Candidates 54 -- 4.4.3 Selection 54 -- 4.4.4 Pilot teams 55 -- 4.4.5 Presentation of results 55 -- 4.5 CONSIDERED INTERVENTIONS .55 -- 4.6 THE LIST OF ACTIVITIES RELATED TO THE INTERVENTIONS 58 -- 4.6.1 Activities for the flap transfer 59 -- 4.6.2 Secondary interventions 60 -- 4.6.3 Re-interventions for complications 62 -- 4.7 CONSIDERED RESOURCES 63 -- 4.8 UNIT COSTS FOR EACH RESOURCE AND COST DRIVERS .64 -- 4.8.1 Unit cost for the work done by plastic surgeons and other resources borne by plastic surgeons 64 -- 4.8.2 The work of the surgeons-in-training .68 -- 4.8.3 The work of the tattoo nurse 69 -- 4.8.4 The work of other medical profiles 69 -- 4.8.5 Cost drivers .69 -- 4.9 DATA COLLECTION PLAN AND TEMPLATES .71 -- 4.10 DATA OVERVIEW AND DATA VALIDATION 72 -- 4.11 RESULTS 74 -- 4.11.1 Time results .74 -- 4.11.2 Cost results .83 -- 4.12 SUMMARY OF MAIN FIGURES AND HANDLING OF UNCERTAINTY 93 -- 4.12.1 Constant duration per technique for start and stop activities .93 -- 4.12.2 Variability in intervention duration and man-hours 93 -- 4.13 STUDY LIMITATIONS 97 -- 5 DISCUSSION AND CONCLUSION 98 -- REFERENCES 101 Link for e-copy: https://doi.org/10.57598/R251C Format of e-copy: PDF (1,56 Mb) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3628 Autologous breast reconstruction techniques after mammary resection / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
![]()
Autologous breast reconstruction techniques after mammary resection : time measurements for a potential reevaluation of the surgeon fee - Supplement [printed text] / Sophie Gerkens, Author ; Stefaan Van de Sande
, Author ; Roos Leroy
, Author ; Anne-Sophie Mertens, Author ; Jonathan Schreiber, Author ; Dries Van Halewyck, Author ; Jan Bellaert, Author ; Hans Van Brabandt
, Author ; Nathalie Swartenbroekx, Author ; Caroline Obyn, Author . - Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre, 2015 . - 85 p. : ill., ; A4. - (KCE Reports. Health Technology Assessment (HTA); 251S) .
ISSN : D/2015/10.273/78 : 0,00
Study 2014-25_HTA_Cost_breast_reconstruction
Languages : English (eng)
Descriptors: Classification
W 74 Medical economics. Health care costs (General)
Indexation
2014-25 ; Costs and Cost Analysis ; Documents related to KCE studies ; Hospital Costs ; Mammaplasty ; Operative Time ; R251 ; Reimbursement Mechanisms ; Surgical FlapsContents note: APPENDICES 4 -- 1 CLINICAL LITERATURE REVIEW 4 -- 1.1 SEARCH STRATEGIES - ELECTRONIC REFERENCE DATABASES: MEDLINE (THROUGH OVID), EMBASE AND THE COCHRANE LIBRARY 4 -- 1.2 STUDY SELECTION AND QUALITY APPRAISAL 10 -- 1.2.1 Flow chart for selection procedure 10 -- 1.2.2 Study selection 11 -- 1.3 QUALITY APPRAISAL OF INCLUDED SYSTEMATIC REVIEWS 13 -- 1.4 EVIDENCE TABLES OF INCLUDED SYSTEMATIC REVIEWS 15 -- 1.4.1 Research question 1: In women who underwent a mastectomy, what is the clinical effectiveness in terms of quality of life in those women who had an autologous breast reconstruction, compared with women who had a breast reconstruction with implants, or a mastectomy without reconstruction? 15 -- 1.4.2 Research question 2: What are the adverse outcomes associated with autologous breast reconstruction? 21 -- 1.4.3 Research question 3: What is the impact of radiotherapy on an autologous breast reconstruction? 27 -- 2 NATIONAL HOSPITAL STAYS DATABASE (NHDB) 34 -- 3 ICD-9-CM PROCEDURE CODES FOR MAMMARY INTERVENTIONS (VERSION DATE: 2015-05-29) 37 -- 4 NIHDI BILLING CODES FOR MAMMARY INTERVENTIONS (VERSION DATE: 2015-05-29) 45 -- 5 ICD-9-CM DIAGNOSES FOR MAMMARY INTERVENTIONS (VERSION DATE: 2015-05-29) 58 -- 6 INCLUSION-EXCLUSION CRITERIA FOR STAYS AND PATIENTS 69 -- 7 FLAGGING CODES AND STAYS FOR BREAST CANCER INVOLVEMENT 70 -- 8 EXHAUSTIVENESS WITH EXTRACTION-INCLUSION-EXCLUSION 75 -- 8.1 INTERVENTIONS IN HBD 75 -- 8.2 INTERVENTIONS IN MCD 76 -- 8.3 APR-DRG LEVEL 78 -- 9 GROUPING INTERVENTIONS AND COMPLICATIONS 79 -- 10 LEAD TIME AND RATIO CALCULATIONS WITH CENSORED DATA 82 -- 10.1 INTERVENTION LEAD TIMES 82 -- 10.2 NUMERATORS & DENOMINATORS 82 -- 10.3 LEAD TIMES STATISTICS 83 -- 10.4 FRACTIONS AND RATIOS 83 -- REFERENCES 85 Link for e-copy: https://doi.org/10.57598/R251S Format of e-copy: PDF (716 Kb) Record link: https://kce.docressources.info/index.php?lvl=notice_display&id=3629 Copies
Barcode Call number Media type Location Section Status No copy Autologous breast reconstruction techniques after mammary resection / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
![]()
PermalinkBariatric surgery / Peter Louwagie / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2019)
![]()
PermalinkBelgian guidelines for economic evaluations and budget impact analyses / Irina Cleemput / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2012)
![]()
PermalinkBenefits and costs of innovative oncology drugs in Belgium (2004-2017) / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
![]()
PermalinkBenefits and costs of innovative oncology drugs in Belgium / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2021)
![]()
PermalinkBevacizumab in the treatment of ovarian cancer / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
![]()
PermalinkBevacizumab in the treatment of ovarian cancer / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
![]()
PermalinkBevacizumab in the treatment of ovarian cancer / Mattias Neyt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2017)
![]()
PermalinkBorstreconstructie na kanker / Sophie Gerkens / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2015)
![]()
PermalinkCardiac resynchronisation therapy / Hans Van Brabandt / Brussels [Belgium] : KCE = Federaal Kenniscentrum voor de Gezondheidszorg = Centre Fédéral d'Expertise des Soins de Santé = Belgian Health Care Knowledge Centre (2011)
![]()
Permalink
